StonvexLoading…
StonvexStonvexStonvexCore line items from CPRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 (Est.) Expected 2026-05-21 | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Annual 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|---|
Revenue | $1.22B | $2.28B | $1.16B | $4.65B | $3.52B |
Operating Income | Not available | $819.40M | $430.69M | $1.70B | $1.28B |
Net Income | Not available | $754.45M | $403.71M | $1.55B | $1.16B |
EPS (Diluted) | $0.41 | $0.77 | $0.41 | $1.59 | $1.18 |
Total Assets | Not available | $10.59B | $10.58B | $10.09B | $9.67B |
Total Liabilities | Not available | $787.73M | $961.90M | $883.41M | $869.52M |
Cash & Equivalents | Not available | $5.10B | $5.23B | $2.78B | $2.37B |
Free Cash Flow OCF − CapEx | Not available | $485.09M | $427.21M | $1.23B | $879.92M |
Shares Outstanding | Not available | 963.29M | 967.90M | 967.48M | 966.81M |